New scientific studies have shown that LAMP (Loop Meditated Isothermal Amplification) based technologies could have a significant role in dealing with endemic diseases such as malaria.
The peer reviewed research which appeared in the Journal of Infectious Diseases shows how LAMP can be used as a tool or the quick and easy diagnosis of malaria in both modernized laboratories and in the field in areas of the world where the disease is endemic.
The studies highlighted the potential of Lumora’s work in this area, and its recent deal with FIND (Foundation for Innovative Novel Diagnostics) which will see the development of a new malaria test using BART (Bioluminescent Assay in Real Time), a technology based on LAMP .
"Using this test requires only a room with very basic laboratory facilities, i.e. electricity," Iveth Gonzalez, a scientific officer and project manager of LAMP projects for malaria and Chagas disease at FIND, and an author on the studies, told PCR Insider. "This test can be used in any microscopy-level clinic in resource-poor nations and doesn’t need standard infrastructure for PCR."
"The current LAMP kit has been developed for case management, and small groups of samples can be tested simultaneously," Gonzalez said. "FIND is working with Lumora [to develop] the next generation of the assay which is a high-throughput format that will allow testing of bigger groups of samples. The application of this assay will mainly be for population screening in elimination campaigns."
In April, Lumora agreed a partnership with FIND to develop a rapid, high-throughput malaria diagnostic assay for screening patients in the developing world.